Pharmaceutical drugs supplied by: Ascent Pharmaceuticals, Inc
✉ Email this page to a colleague
Ascent Pharmaceuticals, Inc
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Ascent Pharms Inc | ICOSAPENT ETHYL | icosapent ethyl | CAPSULE;ORAL | 216811 | ANDA | Ascent Pharmaceuticals, Inc | 43602-291-05 | 500 CAPSULE in 1 BOTTLE (43602-291-05) | 2022-09-02 |
| Ascent Pharms Inc | ICOSAPENT ETHYL | icosapent ethyl | CAPSULE;ORAL | 216811 | ANDA | Ascent Pharmaceuticals, Inc | 43602-291-30 | 30 CAPSULE in 1 BOTTLE (43602-291-30) | 2022-09-02 |
| Ascent Pharms Inc | DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE | amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 214959 | ANDA | Ascent Pharmaceuticals, Inc | 43602-316-05 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43602-316-05) | 2021-09-29 |
| Ascent Pharms Inc | DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE | amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 214959 | ANDA | Ascent Pharmaceuticals, Inc | 43602-316-30 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43602-316-30) | 2021-09-29 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
